Finance

Beta
Lists
CLVLF:OTCMKTS
Clinuvel Pharmaceuticals Ltd
$6.40
0.00%
(0.00) 1D
May 26, 11:17:43 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLVLF...
Mkt. cap
460.41M
Avg. vol.
280.00
Volume
26.00
52-wk high
$8.50
52-wk low
$6.27
Beta
1.03
Shares outstanding
50.43M
No. of employees
16
Mkt. cap
460.41M
Avg. vol.
280.00
Volume
26.00
52-wk high
$8.50
52-wk low
$6.27
Beta
1.03
Shares outstanding
50.43M
No. of employees
16
News stories
From sources across the web
About Clinuvel Pharmaceuticals Ltd
CEO-
Employees16
Founded1999
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
29.68M
29.68M
18.47M
18.47M
Cost of goods sold
2.71M
2.71M
2.28M
2.28M
Cost of revenue
2.71M
2.71M
2.28M
2.28M
Research and development expenses
2.28M
2.28M
1.70M
1.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.18M
9.18M
6.96M
6.96M
Operating expense
12.23M
12.23M
9.42M
9.42M
Total operating expenses
14.94M
14.94M
11.71M
11.71M
Operating income
14.74M
14.74M
6.76M
6.76M
Other non operating income
-
-
-
-
EBT including unusual items
14.81M
14.81M
7.29M
7.29M
EBT excluding unusual items
14.81M
14.81M
7.29M
7.29M
Income tax expense
3.76M
3.76M
2.07M
2.07M
Effective tax rate
25.40%
25.40%
28.39%
28.39%
Other operating expenses
-12.09K
-12.09K
-1.24K
-1.24K
Net income
11.05M
11.05M
5.22M
5.22M
Net profit margin
37.22%
37.22%
28.28%
28.28%
Earnings per share
-
-
-
-
Interest and investment income
2.41M
2.41M
2.63M
2.63M
Interest expense
-1.24M
-1.24M
-1.28M
-1.28M
Net interest expenses
1.16M
1.16M
1.35M
1.35M
Depreciation and amortization charges
286.78K
286.78K
250.02K
250.02K
EBITDA
14.83M
14.83M
7.01M
7.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more